COVID-19の発生は、避妊具市場の価値に大きな影響を与えました。この発生は、経済に影響を及ぼした重大な病気の負担と財政的逆境をもたらしました。コロナウイルスのパンデミックの間に、世界中の何百万もの女性や少女が避妊および中絶サービスへのアクセスを失いました。ロックダウン、旅行制限、サプライチェーンの混乱、COVID-19に対抗するための医療資源の大規模な移動、感染の恐怖が、国内での意図しない妊娠の増加に寄与しました。旅行制限の結果、国内での安全でない中絶の発生率は、避妊具の不足により急増しました。コンドーム同盟の2020年の報告によれば、2020年のロックダウン期間中に国でのコンドーム販売は52％減少し、2021会計年度には年間31％の減少が見込まれています。このように、Covid-19は避妊具市場に大きな影響を与えました。

• 1 イントロダクション

  • 1.1 調査の前提条件と市場の定義

  • 1.2 本調査の範囲

• 2 調査手法

• 3 エグゼクティブサマリー

• 4 市場ダイナミクス

  • 4.1 市場概要

  • 4.2 市場の促進要因

    • 4.2.1 性感染症（STD）に対する意識の向上

    • 4.2.2 意図しない妊娠の増加

  • 4.3 市場の抑制要因

    • 4.3.1 避妊具の使用に伴う副作用について

  • 4.4 ポーターのファイブフォース分析

    • 4.4.1 新規参入の脅威

    • 4.4.2 買い手・消費者の交渉力

    • 4.4.3 サプライヤーの交渉力

    • 4.4.4 代替品の脅威

    • 4.4.5 競合・競争状況の激しさ

• 5 市場セグメンテーション（市場規模別、金額、百万米ドル）

  • 5.1 タイプ別

    • 5.1.1 コンドーム

    • 5.1.2 ダイヤフラム

    • 5.1.3 頚椎用キャップ

    • 5.1.4 スポンジ

    • 5.1.5 ヴァージナルリング

    • 5.1.6 子宮内避妊器具（IUD）

    • 5.1.7 その他のタイプ

  • 5.2 男女別

    • 5.2.1 男性

    • 5.2.2 女性

• 6 競合情勢

  • 6.1 企業プロファイル

    • 6.1.1 Reckitt Benckiser

    • 6.1.2 Cooper Surgical Inc

    • 6.1.3 Abbvie Inc (Allergan PLC)

    • 6.1.4 Merck & Co., Inc

    • 6.1.5 Bayer AG

    • 6.1.6 Mylan Laboratories

    • 6.1.7 Okamoto Industries, Inc

    • 6.1.8 Pfizer Inc

• 7 市場機会と今後の動向

The Japan Contraceptive Devices Market size is estimated at USD 638.27 million in 2024, and is expected to reach USD 850.94 million by 2029, growing at a CAGR of 5.92% during the forecast period (2024-2029).

Certain factors that are driving the market growth include the increasing awareness about sexually transmitted diseases (STDs) and the rising rate of unintended pregnancies.

The outbreak of COVID-19 has significantly impacted the contraceptives market value. The outbreak inflicted a substantial disease burden along with financial adversities that have impacted the economy. While during the coronavirus pandemic, millions of women and girls worldwide lost access to contraception and abortion services. Lockdowns, travel restrictions, supply chain disruptions, a massive shift of health resources to combat COVID-19, and the fear of infection had all contributed to an increase in the number of unintended pregnancies in the country. As a result of travel restrictions, the incidence of unsafe abortions in the country had led to rising pregnancy exponentially due to a lack of contraceptives. According to a report by the Condom Alliance 2020, condom sales in the country fell 52 percent during the lockdown period in 2020, with a projected full-year decline of 31 percent for FY2021. Thus, Covid-19 has had a significant impact on the market for contraceptive devices.

According to the United Nations Department of Economic and Social Affairs, estimated that in 2020, the contraception usage among the female Japanese population stood at around 56.6 percent and this percentage is expected to reach 62.5 percent by 2030. Moreover, initiatives by the government to raise awareness regarding contraceptives and family planning have also helped the growth of the market. Thus, owing to the above-mentioned factors it is expected to drive market growth. While the increasing burden of sexually transmitted diseases in Japan is further propelling the market growth. For instance , In April 2020, around 28.4 thousand cases of chlamydia were reported by medical institutions in Japan, representing the highest number in the last decade, and at the same time making it the most common STD of Japan. In the same year, the recorded cases of herpes genitalis amounted to exactly nine thousand.

Thus, the aforementioned reasons are driving the market growth.

Japan Contraceptive Devices Market Trends

Condoms are Expected to Dominate the Market Over the Forecast Period

A condom is a sheath-shaped barrier device that is being used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms available in the market. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.

Moreover, in Japan, Okamoto Industries has the widest condom range. In 2020, Okamoto in collaboration with Condomania is also debuting Japanese-themed condoms, as well as the world's first condoms coated with a special microbicide that has been shown in medical studies to inactivate up to 99.9 percent of HIV, HSV, and HPV. Thus, considering the above-mentioned factors it is expected to show significant growth shortly.

The government in Japan is introducing different campaigns and comprehensive sex education programs to improve awareness among youth and encourage them to use contraceptives in order to combat STDs and prevent unwanted pregnancies. In Japan, the Ministry of Health and Family Welfare procures condoms that are distributed by NACO/SACS to high-risk groups (HRGs) via TI NGOs/ICTC/ART centres for HIV/AIDS prevention. Whereas, in the National Department of Health (NDOH) is working to ensure that male condoms are readily available in all communities throughout the region.

Thus, the aforementioned factors are propelling the growth of the market.

Japan Contraceptive Devices Industry Overview

The Japan Contraceptive Devices Market is fragmented in nature. Moreover, Japan has been witnessing the emergence of some small players due to presence of high awareness. This has also helped the studied market to grow. Some of the market players include Reckitt Benckiser, Cooper Surgical Inc., Abbvie Inc (Allergan PLC), Merck & Co., Inc, Mylan Laboratories, Okamoto Industries, Inc, Pfizer Inc., and Bayer AG.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

• 1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition

  • 1.2 Scope of the Study

• 2 RESEARCH METHODOLOGY

• 3 EXECUTIVE SUMMARY

• 4 MARKET DYNAMICS

  • 4.1 Market Overview

  • 4.2 Market Drivers

    • 4.2.1 Increasing Awareness about Sexually Transmitted Diseases (STDs)

    • 4.2.2 Rising Rate of Unintended Pregnancies

  • 4.3 Market Restraints

    • 4.3.1 Side Effects Associated with the Use of Contraceptive Devices

  • 4.4 Porter's Five Force Analysis

    • 4.4.1 Threat of New Entrants

    • 4.4.2 Bargaining Power of Buyers/Consumers

    • 4.4.3 Bargaining Power of Suppliers

    • 4.4.4 Threat of Substitute Products

    • 4.4.5 Intensity of Competitive Rivalry

• 5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type

    • 5.1.1 Condoms

    • 5.1.2 Diaphragms

    • 5.1.3 Cervical Caps

    • 5.1.4 Sponges

    • 5.1.5 Vaginal Rings

    • 5.1.6 Intra Uterine Device (IUD)

    • 5.1.7 Other Types

  • 5.2 By Gender

    • 5.2.1 Male

    • 5.2.2 Female

• 6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles

    • 6.1.1 Reckitt Benckiser

    • 6.1.2 Cooper Surgical Inc

    • 6.1.3 Abbvie Inc (Allergan PLC)

    • 6.1.4 Merck & Co., Inc

    • 6.1.5 Bayer AG

    • 6.1.6 Mylan Laboratories

    • 6.1.7 Okamoto Industries, Inc

    • 6.1.8 Pfizer Inc

• 7 MARKET OPPORTUNITIES AND FUTURE TRENDS